Chris Masterjohn
π€ SpeakerAppearances Over Time
Podcast Appearances
So that's mitochondrial biogenesis number one.
But CoQ10 will help with that.
You don't always want,
I do think like testing is another case where that might be a case where like you could use a high dose CoQ10 to try to stimulate more mitochondria if testing shows that you don't have enough and that's your like limiting bottleneck.
But the average person whose CoQ10 levels are just a little lower where they should be, it really is just acting as that, kind of like you open up the biochemistry textbook, you see the place of CoQ10 in the mitochondrial energy production pathways, and it's just doing the basic textbook thing of helping you move those electrons along on the path to convert food to ATP.
Seed oils make your tissues more vulnerable to damage, and they don't damage your tissues.
And so one of the problems that has caused a lot of controversy, and I think the reason there's so much back and forth over this,
is that it takes the right type of study to see seed oils making your tissues more vulnerable to damage because you need enough time for the damage to play out and you need people who are more vulnerable to the damage.
And we've been talking a lot today about how aging is increasing that tissue damage.
Like everything is, your repair capacity goes down as you grow older because your mitochondrial energy production is going down.
And one of the things you want to look at is
what do seed oils do to you by the time you're 75?
And you don't just want to look at what do seed oils do to you when you're 25, because you might not be seeing the capacity for the increased vulnerability of tissue damage.
Another thing is the trials have to be long enough, both because it takes time to see the process of tissue damage play out, and also because we know from long trials of seed oils that
that short trials are useless.
A lot of the people who are talking the loudest in defense of seed oils are looking at trials that last seven weeks long or 12 weeks long, and they're ignoring trials that were done in the 50s, 60s, and 70s that were five to eight years long.
by all means, analyze the shorter trials, but do it in the light of what we know from the longer trials.
And the most important of the longer trials was the LA Veterans Administration Hospital Study,
And this was the primary paper on it was published in 1969.